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Synopsis
The removal efficacy of the USEPA Contaminant Candidate List viruses is
evaluated under enhanced coagulation conditions using varying FeCl 3 doses
and pH.

Abstract
Enhanced coagulation was evaluated for removal efficacy of coxsackievirus
and echovirus (Contaminant Candidate List [CCL] enteroviruses), poliovirus,
four potential surrogate bacteriophages, and dissolved organic carbon (DOC).
Viruses and DOC were effectively removed using enhanced coagulation, with
removals generally improving as dose increased and pH decreased. Optimal
enhanced coagulation conditions of 40 mg/L FeCl 3 and pH between 5 and 6.5
resulted in a maximum removal of 3.0 logs of coxsackievirus B6, 1.75 logs of
echovirus 12, 2.5 logs of poliovirus 1, 1.8 logs of fr, 1.3 logs of phi-X174,
0.36 logs of MS2, 0.29 logs of PRD1, and 41% DOC. Bacteriophages fr and
phi-X174 appear to be the most representative surrogates for the physical
removal of coxsackievirus, while MS2 and PRD1 are more conservative. For
echovirus, MS2 and PRD1 appear to be the most appropriate surrogates. The
relative removal profiles of the enteroviruses (greatest removal of
coxsackievirus followed by poliovirus and then echovirus) suggest that studies
of the physical removal of poliovirus may be extended to the CCL
enteroviruses. These results contribute to evaluations of the CCL and
regulatory status of coxsackievirus and echovirus and aid in building a
database of the treatment efficiencies of enteroviruses and their surrogates.

Introduction
In an effort to ensure the safety of the nation’s drinking water,
the United States Environmental Protection Agency (USEPA)
continually develops and re-evaluates regulations targeting drinking
water contaminants. Recently promulgated regulations such as the
Long-term 2 Enhanced Surface Water Treatment Rule (LT2) and the
Disinfectants and Disinfection Byproduct Rule (DBPR) are shifting the
focus of treatment processes such as coagulation in an attempt to
simultaneously balance the risks posed by microbial and chemical
contaminants. Strategies for mitigating contaminants of emerging
concern, such as disinfection byproducts (DBPs), are specifically
emphasized in these regulations. The removal of DBP precursors such
as dissolved organic carbon (DOC) prior to disinfection is an effective
means of limiting DBP formation. Enhanced coagulation using
increased coagulant dose and/or pH adjustment was identified by the
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DBPR as the best available technology for DOC removal (1). The Stage
1 DBPR requires many systems using surface water, or groundwater
directly under the influence of surface water, to implement enhanced
coagulation.2
Although substantial efforts have been devoted to assessing the
removal of DBP precursors from drinking water using enhanced
coagulation,1,3-5 limited information is available regarding the efficacy
of enhanced coagulation for the removal of emerging pathogens.6-8
Conventional coagulation, flocculation, and sedimentation processes
have demonstrated efficiency in the removal of viruses, bacteria, and
protozoa.9-11 Similar studies are needed to evaluate the effect of
enhanced coagulation optimization for the reduction of DOC on the
removal of emerging pathogens, such as those on the USEPA’s
Contaminant Candidate List (CCL). The CCL is a list of currently
unregulated contaminants warranting priority research since they are
known or believed to occur in public water systems and may represent
a public health risk. The current CCL (CCL 2, published in February
2005) includes four viruses: adenovirus, calicivirus, coxsackievirus,
and echovirus.12 The physical removal of adenovirus and calicivirus
was examined in the companion study,7 while this study focused on
the removal of coxsackievirus and echovirus under enhanced
coagulation conditions.
Although relatively limited data is available regarding the
treatment of coxsackievirus and echovirus in drinking water systems, a
great deal of information exists regarding the treatability of the
prototype enterovirus, poliovirus. As the first virus propagated in
tissue culture,13 poliovirus is perhaps the most recognized and widely
studied of all viruses. Should similarities be observed between the
removal profiles of the CCL viruses and poliovirus, it may be possible
to extend studies of the removal of poliovirus to coxsackievirus and
echovirus. Accordingly, poliovirus was also included in this study.
In addition to the enteroviruses, bacteriophages MS2, PRD1,
phi-X174, and fr were included as potential surrogates for the physical
removal of coxsackievirus and echovirus. Bacteriophages share many
similarities with human viruses (e.g., size, isoelectric point, etc., as
shown in Table 1) but are faster, less expensive, and easier to assay
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(7). Bacteriophages having removal profiles similar to those of the CCL
viruses may be valuable surrogates for studies of enterovirus removal.
The results of this study will aid in building a database of treatment
efficacies of enteroviruses and their surrogates and in evaluating their
CCL and regulatory status.
Table 1. Virus Characteristics
CCL virus

cell line

isoelectric
pointa

sizea(nm)

genetic
structure

coxsackievirus (ATCC
VR-155)

buffalo green
monkey kidney
(BGM)

24−30

b

Singlestranded RNA

echovirus (ATCC VR1563)

buffalo green
monkey kidney
(BGM)

24−30

b

Singlestranded RNA

poliovirus type 1c
(strain Lsc-2ab)

buffalo green
monkey kidney
(BGM)

24−30

7.0−8.2 (A
state)d

Singlestranded RNA

bacteriophage

bacterial host

sizea(nm)

isoelectric
pointa

genetic
structure

MS2(ATCC 15597B1)

Escherichia coli (ATCC
15597)

24−27

3.5−3.9

singlestranded RNA

PRD1(ATCC BAA769-B1)

Salmonella
62−65
typhimurium LT2 (ATCC
19585)

3.0−4.2

doublestranded DNA

phi-X174(ATCC
13706-B1)

Escherichia coli (ATCC
13706)

6.6

singlestranded DNA

23−27

fr(ATCC 15767-B1) Escherichia coli (ATCC 19−23
8.9−9.0
single19853)
stranded RNA
aAs summarized by Mayer, 20086 and Abbaszadegan, 20077.
bDetermination of the isoelectric points of pathogenic viruses is very difficult, and few
have been reported. The isoelectric points of coxsackievirus and echovirus have not
yet been determined by empirical means.
cPoliovirus is not a CCL virus, but it shares many similarities with coxsackievirus and
echovirus, and it was included in this study for comparative purposes.
dAs described by Mayer, 2008,6 some enteroviruses have two conformational states (A
and B), each with its own isoelectric point.

Materials and Methods
Jar Testing
A series of bench-scale jar tests was performed to optimize
ferric chloride dose and pH with respect to DOC removal. To prevent
interference between parameters, separate tests using identical
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enhanced coagulation treatments were conducted to develop removal
profiles for coxsackievirus, echovirus, poliovirus, the four
bacteriophages, and DOC. Untreated central Arizona surface water of
turbidity 9−22 NTU, pH 7−8, alkalinity 140−260 mg/L as CaCO3, and
DOC 4 mg/L was used. A 10 L water sample (at 20 °C) was seeded
with a known number of viruses (final concentration of 106 plaque
forming units [PFU] per mL of each bacteriophage or 103.5 50% tissue
culture infectious dose [TCID50] per mL of each enterovirus). A sample
of the seeded water was collected for determination of initial virus
concentrations. The water was distributed to a Phipps & Bird PB-700
(Richmond, VA) jar test apparatus at a volume of 1.5 L per jar. Ferric
chloride (ferric chloride hexahydrate lumps, Sigma Chemical Co., St.
Louis, MO), cationic polymer (polydiallyldimethyl ammonium chloride
[polyDADMAC], Clarifloc 350, Polydyne, Inc., Riceboro, GA), and 1 N
HCl were immediately added, as described in the following paragraph.
Ferric chloride was used in this study because it has
demonstrated improved organic removal compared to alum.14 Doses
are heavily dependent on water quality, and are therefore widely
variable.15 Enhanced coagulation doses range from 5 to 150 mg/L
FeCl3,14 but more commonly range from 20 to 60 mg/L FeCl3.4 In this
study, coagulant doses ranging from 20 to 120 mg/L FeCl3 were tested
in increments of 20 mg/L in an effort to optimize coagulant dose.
Variations in polymer dose have not demonstrated a significant effect
on DOC removal during enhanced coagulation;1 therefore, polymer
was applied at a constant dose of 0.4 mg/L. At the previously
determined optimal coagulant dose, pH adjustment was evaluated in
order to identify the optimal pH. Coagulation of natural organic matter
with ferric chloride is typically optimized at a pH of approximately
4−5;3,5 however, for practical reasons, enhanced coagulation is
generally carried out in a pH range of 5−7.1 At the optimal coagulant
dose, target pH values ranging from 5.5 to 7.0 were tested using
increments of 0.5 as part of this investigation.
Immediately following chemical addition, the jars were mixed at
100 rpm for 1 min, 40 rpm for 10 min, 20 rpm for 10 min, and no
mixing for 30 min, as described by Volk et al.4 Samples were assayed
for bacteriophages or enteroviruses, DOC, pH, turbidity, and ultraviolet
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absorbance at a wavelength of 254 nm (UV254), all of which have the
potential to affect the efficacy of coagulation.

Virus Propagation and Assays
Bacteriophages MS2 (ATCC 15597-B1), phi-X174 (ATCC 13706B1), fr (ATCC 15767-B1), and PRD1 (ATCC BAA-769-B1) and their
respective bacterial hosts E. coli (ATCC 15597, 13706, and 19853) and
S. typhimurium LT2 (ATCC 19585) were obtained from the American
Type Culture Collection (ATCC, Rockville, MD). Bacteriophage stocks
were propagated using the double agar layer (DAL) method.16 The
bacteriophages were eluted from the plates using 10 mL of buffered
demand free (BDF) water (0.54 g Na2HPO4 and 0.88 g KH2PO4 per liter
of nanopure water, pH 7.0). The supernatant was collected and
centrifuged at 4 °C at 1200g for 15 min to remove bacteria. To
minimize DOC content, the stocks were purified using two successive
polyethylene glycol (PEG) precipitations followed by a Vertrel XF (Micro
Care Marketing Services, New Britain, CT) extraction and resuspension
in BDF, as described by Thurston-Enriquez et al.17 Briefly, the
suspension was augmented with 9% PEG (MW 8000) and 1 M NaCl
and was allowed to stir overnight at 4 °C. It was then centrifuged at
4 °C at 8000g for 90 min. The supernatant was discarded, and the
pellet was resuspended in 10% of its original volume of BDF water. To
remove lipids and facilitate the monodispersion of viruses, a Vertrel XF
extraction was performed by centrifuging a suspension of equal parts
Vertrel and virus at 4 °C at 8000g for 90 min.17 The supernatant
containing the purified viruses (typically on the order of 1010 PFU/mL)
was stored at 4 °C.
Coxsackievirus B6 Schmitt (ATCC VR-155) and echovirus 12
Travis (ATCC VR-1563) were obtained from the ATCC. Poliovirus type
1 (attenuated strain Lsc-2ab) was kindly provided by Dr. Charles P.
Gerba of the University of Arizona. All viruses were cultured using
conventional in vitro cell culture techniques in a continuous buffalo
green monkey kidney (BGM) cell line in 1X Eagle’s minimum essential
medium (MEM) containing 5% fetal bovine serum (FBS). For virus
propagation, the cells were inoculated with approximately 1 × 106
TCID50/mL of virus and incubated at 37 °C until at least 90% infected.
Three freeze/thaw cycles were used to facilitate the release of the
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virus particles. The supernatant was collected and centrifuged at 4 °C
at 1200g for 15 min to remove cellular debris. Virus stocks were
purified using two successive PEG precipitations, a Vertrel XF
extraction, and resuspension in BDF water, as described previously.
The purified viruses (typically on the order of 106 TCID50/mL) were
stored at × 80 °C.
Immediately following jar test experiments, the water samples
were serially diluted (10-fold) in BDF water (sufficient for up to 5-log
removal of bacteriophages and 3.5-log removal of enteroviruses). The
bacteriophages were assayed in triplicate using the DAL method,16 and
the enteroviruses were assayed using conventional in vitro cell culture
techniques. Positive and negative controls were included in each set of
assays. For cell culture, BGM cells were grown in 24-well trays. Each
sample dilution was used to inoculate four wells, using 0.1 mL of
sample per well. The trays were incubated in a 5% CO2 incubator at
37 °C and were examined daily for up to 14 days for cytopathogenic
effects (CPE) in the form of cell enlargement, rounding, and
detachment. The Karber TCID50 method was used to quantify the viral
concentration of each sample, as described by Abbaszadegan et al.7
The log reduction of bacteriophages and enteroviruses (−log[Nt/N0],
where Nt is the number of viruses in the treated sample and N0 is the
number in the original sample) was calculated for each enhanced
coagulation treatment condition.

Chemical Parameter Analysis
The pH was measured using a Mettler (Columbus, OH) pH
meter. Turbidity was measured using a Hach (Loveland, CO) model
2100P turbidimeter. For DOC determination, samples were filtered
using 1.2 μm Whatman (Middlesex, UK) GF/C glass microfiber filters,
acidified using 1 N HCl, and analyzed using a Shimadzu 5050A (Kyoto,
Japan) total organic carbon analyzer. A Shimadzu Multispec 1501 was
used to measure UV254. UV254 was used to calculate specific UV
absorbance (SUVA = UV254/DOC, [L(mg × m)−1]), which is sometimes
used as a surrogate measurement of DBP precursors.14
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Statistical Analysis
Statistical analyses were performed to determine if the mean
bacteriophage removals resulting from different treatment conditions
were statistically different at a significance level of α = 0.05. SPSS
(Chicago, IL) Version 12.0 statistical software was used to compute
the Levene statistic, analysis of variance (ANOVA), Welch test, Tukey’s
honestly significant difference (HSD) test, and the Games-Howell test,
as described by Abbaszadegan et al.7 Statistics were also used to test
for correlations between virus removals and their respective isoelectric
points and sizes. Using Microsoft Excel, Pearson product moment
correlations (as described by Karl Pearson in 1895)18 and linear
regression models were computed and used to evaluate the
relationship between the variables.

Results and Discussion
Coagulant Dose Optimization Jar Tests
The coagulant dose optimization jar tests (performed without pH
adjustment) demonstrated that bacteriophage removal generally
increased as coagulant dose increased (Figure 1). Overall, fr was
removed to the greatest extent, followed by phi-X174, PRD1, and
MS2. Statistical analyses were performed using the mean log removals
of the bacteriophages (n = 3) at different coagulant doses to
determine the optimal dose required to produce significant virus
removal. For each of the four bacteriophages, there was a significant
difference between log removals at different coagulant doses (P ≤
0.05), as shown in Table 1 in the Supporting Information. The optimal
dose for the removal of each bacteriophage (as summarized in Table
2) was identified as the lowest dose at which a significant
improvement in removal was observed with incremental increases in
coagulant dose (P ≤ 0.05), but beyond which, removals did not
significantly improve. The results of the statistical analyses are
provided in Table 2 in the Supporting Information.
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Figure 1. Removal of microbes and DOC as a function of FeCl3 dose in the first jar
test. The error bars represent ±1 standard deviation for the bacteriophages and ±5%
for the enteroviruses and DOC.

Table 2. Summary of Optimal Treatment Conditions
variable

coagulant dose (mg/L FeCl3)

pH (at 40 mg/L FeCl3)

MS2

60

PRD1

≥100

<6.5

phi-X174

100

6.0

fr

40

<6.5

coxsackievirus

100−120 (first test); 60 (2nd test) <6.5
(1st test); < 6.0 (2nd test)

echovirus

120 (1st test); 60 (2nd test)

<7.0 (1st test); < 6.0 (2nd test)

poliovirus

120(1st test); 60 (2nd test)

<5.5

DOC

100 (1st test); 60 (2nd test)

<6.5

overall
recommendation

40

<6.5

Due to the time- and material-intensive nature of the in vitro
cell culture assay, one replicate was analyzed for each of the two
independent enterovirus experiments. Since water quality varied
between tests, they were not considered replicates, and statistical
analyses were not employed to determine the optimal coagulant dose
for enterovirus removal. However, the data in Figure 1 (for the first
virus test) indicate that although some improvement in enterovirus
removal was observed at low coagulant doses, consistent
improvements were achieved only at the high end of the dose range.
Based on the results of the first test, a second enterovirus jar test was
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performed, thereby providing a second independent data set. For the
second test, the coagulant dose range was narrowed to 20, 40, and 60
mg/L FeCl3, based on improved performance and practicality under
these conditions, as indicated by the results of the bacteriophage and
first CCL virus test results. The results of the second test are shown in
Figure 2. Again, they suggest that enterovirus removal improves
throughout the dose range tested. Relative to one another,
coxsackievirus B6 (CoxB6) was consistently removed to the greatest
extent, followed by poliovirus 1 (Polio1), and then echovirus 12
(Echo12).

Figure 2. Removal of microbes and DOC as a function of FeCl3 dose in the second jar
test. The error bars represent ±5%.

CoxB6 was consistently removed to a greater extent than phiX174, PRD1, and MS2. This suggests that these microbes may be
acceptable surrogates for CoxB6 since the treatment required for their
removal would remove CoxB6 to an even greater extent. The removal
of phi-X174 was more similar to that of CoxB6, suggesting that phiX174 would be more representative, while MS2 and PRD1 would be
more conservative surrogates since they were removed to a lesser
extent. The removal profile of bacteriophage fr was most similar to
CoxB6; however, its suitability as a surrogate was questionable since it
was sometimes removed more efficiently than CoxB6. Echo12 was
consistently removed to a lesser extent than CoxB6, and was also
generally removed to a lesser extent than bacteriophages fr and phiEnvironmental Science & Technology, Vol 42, No. 18 (September 15, 2008): pg. 6890-6896. DOI. This article is © American
Chemical Society and permission has been granted for this version to appear in e-Publications@Marquette. American
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X174. This indicates that fr and phi-X174 would not be suitable
surrogates, while MS2 and PRD1 may be appropriate surrogates since
they were removed to a similar, but lesser extent than Echo12.
Coagulation processes typically target the removal of organic
matter, such as DOC, whereas virus removal is considered an ancillary
benefit. Accordingly, optimal coagulant doses are generally selected on
the basis of DOC removal, regardless of the optimal dose range for
virus removal. The USEPA’s Enhanced Coagulation Guidance Manual2
requires a 25% reduction in DOC to satisfy the enhanced coagulation
requirements for this source water (total organic carbon of 4.0−8.0
mg/L and alkalinity >120 mg/L as CaCO3). This condition was satisfied
using doses of 100−120 mg/L FeCl3 (Table 3). In this range,
substantial decreases in turbidity, UV254, and SUVA (all measures of
the efficacy of coagulation) were also observed. For enhanced
coagulation, the optimal coagulant dose is defined as the point of
diminishing return (PODR).2 The PODR is the dose at which the change
in DOC removal divided by the change in coagulant addition drops to
(and subsequently remains below) 0.03.2 Using the PODR criteria, the
optimal dose for DOC removal was 100 mg/L FeCl3 in the first test and
60 mg/L FeCl3 in the second test. These doses exceed those typically
used at water treatment facilities, but can be reduced using pH
adjustment to improve DOC removal. Consequently, pH optimization
tests were performed using a more moderate coagulant dose of 40
mg/L FeCl3 and pH adjustment, as described in the following section.
Table 3. Chemical Parameters for Jar Tests
FeCl3dose
(mg/L)

pH

DOC
(mg/L)

DOC%
removal)

Δ
DOC/Δ
dose

turbidity UV254
(NTU)
(cm-1)

SUVA
(L/(mg ×
m))

bacteriophage and first CCL virus jar test
0

8.10 4.24

9.18

0.090

2.1

20

7.04 3.93

7.3%

40

6.92 3.97

6.4%

0.02

1.87

0.061

1.6

0.00

2.04

0.044

1.1

60

6.51 3.61

80

6.35 3.29

14.9%

0.02

1.24

0.032

0.9

22.4%

0.02

1.18

0.027

0.8

100
120

6.11 2.60

38.7%

0.03

1.61

0.021

0.8

6.03 2.38

43.9%

0.01

1.27

0.018

0.8

40

7.0 3.97

6.4%

0.61

0.044

1.1

40

6.5 3.50

17.5%

0.65

0.042

1.2

40

6.0 2.76

34.9%

0.71

0.033

1.2
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FeCl3dose
(mg/L)

pH

DOC
(mg/L)

DOC%
removal)

40

5.5 2.49

0

7.15 4.54

20

6.82

40

6.53 4.20

7.5%

60

6.28 4.10

9.7%

40

6.0 3.46

7.5%

40

5.5 3.45

24.0%

Δ
DOC/Δ
dose

41.3%

turbidity UV254
(NTU)
(cm-1)
0.73

SUVA
(L/(mg ×
m))

0.025

1.0

22.2

0.075

1.6

2.83

0.063

1.43

0.047

1.1

1.04

0.040

1.0

1.43

0.047

1.1

0.69

0.030

0.9

second CCL virus jar test

0.01

pH Optimization Jar Tests
For the pH optimization jar tests (as in the dose adjustment jar
tests), bacteriophage fr was generally removed to the greatest extent,
followed by phi-X174, MS2, and PRD1 (Figure 3). Overall,
bacteriophage removal improved slightly in response to reductions in
pH. The removals of MS2, phi-X174, and fr demonstrated significant
improvement as pH incrementally decreased from 8.0 to 5.5 (P ≤
0.05), whereas PRD1 removal did not improve significantly (Table 3 in
the Supporting Information). Statistical analyses were performed using
the mean log removals of the bacteriophages at different pH values to
determine the optimal pH required to produce significant virus
removal. The optimal pH (as summarized in Table 2) was identified as
the highest pH at which significant improvement in removal was
observed as pH decreased, but beyond which, significant
improvements were not observed. The results of the statistical
analyses are provided in Table 4 in the Supporting Information.
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Figure 3. Removal of microbes and DOC as a function of pH adjustment at a
coagulant dose of 40 mg/L FeCl3 in the first jar test. The error bars represent ±1
standard deviation for the bacteriophages and ±5% for the CCL viruses and DOC
removals.

Figures 3 and 4 illustrate that enterovirus removals generally
improved as the pH decreased, although statistical analyses could not
be employed to verify this observation, as described previously. For
the first virus test (Figure 3), the removal of CoxB6 improved as the
pH decreased from 7.0 to 6.5, and again as pH decreased to 6.0. No
additional removal was observed when the pH was decreased to 5.5,
thereby suggesting an optimal pH for CoxB6 removal of less than 6.5.
For Echo12, no additional removal was observed for pH adjustments
below 6.5, thereby indicating that pH values less than 7.0 were
optimal. The removal of Polio1 appeared to improve with each
incremental reduction in pH. Based on these results, a second virus
test was performed at pH values of 6.5, 6.0, and 5.5 (Figure 4). The
second test again suggested that virus removal improved as the pH
decreased. As in the dose optimization tests, CoxB6 was removed to a
greater extent than Polio1, followed by Echo12. The consistency of the
relative removal profiles of the enteroviruses suggests that studies of
the physical removal of poliovirus may be extended to the CCL
enteroviruses, which may contribute to evaluations of their CCL and
regulatory status.
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Figure 4. Removal of microbes and DOC as a function of pH adjustment at a
coagulant dose of 40 mg/L FeCl3 in the second jar test. The error bars represent ±5%.

CoxB6 was consistently removed to a greater extent than
bacteriophages phi-X174, PRD1, and MS2, and also exceeded fr
throughout most of the pH range tested. This suggests that the
bacteriophages may be acceptable surrogates for CoxB6. The removals
of fr and phi-X174 were the most similar to CoxB6, suggesting that
they would be more representative surrogates, whereas MS2 and
PRD1 would be more conservative surrogates since they were removed
to a lesser extent. Echo12 was consistently removed to a lesser extent
than CoxB6. It was also removed to a lesser extent than bacteriophage
fr, indicating that fr would not be a suitable surrogate. Although
Echo12 was removed to a greater extent than phi-X174 for most of
the pH range, phi-X174 was removed to a greater extent at pH 5.5.
Thus, the suitability of phi-X174 as a surrogate for Echo12 was
questionable. Regardless, MS2 and PRD1 were consistently removed to
a lesser extent than Echo12, thereby indicating that they may be
appropriate surrogates.
The pH optimization jar tests satisfied the USEPA enhanced
coagulation guidelines2 by achieving at least 25% DOC removal below
pH 6.5 in the first test (Table 3). Decreases in pH also resulted in
decreases in UV254 and SUVA. Although an optimal pH cannot be
determined using the PODR calculation, as done to optimize dose
(since the PODR is calculated relative to coagulant dose increments),
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the data suggests that the optimal pH range is less than 6.5 based on
improved DOC removal in this pH range. Practical limitations
effectively impart a lower pH boundary of 5;3 thus, the optimal pH
range for DOC removal was 5.0−6.5.

Virus Removal Mechanisms
The quantification of virus removal during physical and chemical
separation processes is well documented.19-21 The main mechanism for
the physical removal of viruses appears to be adsorption and charge
neutralization followed by gravitational separation; however, the
details of virus adsorption during coagulation and flocculation are not
yet fully understood. Studies of transport through soil matrices have
reported that the adsorption of viruses is a complex process in which
hydrophobicity, surface charge, and isoelectric point (pI) are influential
factors.22,23 While it appears that no individual factor can adequately
explain the mechanism of virus adsorption, pI has been suggested to
be the dominant factor controlling virus adsorption during transport
through sandy soils.22 The complete effects of the addition of
coagulant, specifically on the surface charge of the virus, are not fully
understood, but the pI may help to explain adsorption during
coagulation.
The pI of fr is relatively high (Table 1), meaning that its surface
is positively charged in pH ranges encountered during coagulation (5–
8), whereas MS2 and PRD1 would be negatively charged and phi-X174
may be either. For negatively charged particulate matter, the
bacteriophage pIs generally support the observed removal trend (fr >
phi-x174 > PRD1 > MS2). The relatively high stability (low physical
removal) of MS2 is consistent with previous studies of filtration.24
Relative to the other viruses, the pI of poliovirus is more similar to fr,
perhaps suggesting that poliovirus removal would more closely
resemble fr removal compared to the other bacteriophages. This
hypothesis appears to be supported by the data shown in Figures 1
and 3. Pearson correlation coefficients and linear regression models
were used to evaluate the linear relationship between virus removal
and their respective pIs and sizes (averages from Table 1). The
statistics were computed separately for each treatment condition (jar
test, coagulant dose/pH tested) to eliminate extraneous factors that
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would affect microbial removal other than their physical
characteristics. This essentially “leveled the field” so that the
relationship between the variables was evaluated for a given water
matrix and level of treatment. The results (Table 5 in the Supporting
Information) indicated that virus removal was strongly correlated to
isoelectric point (−0.05 < Pearson <0.0525 and R2 > 0.80), but the
relationship between virus removal and size was not nearly as strong.
Thus, while the exact mechanisms of adsorption cannot be identified
as a result of this study, the results suggest that pI plays a role in
virus removal by adsorption.

Summary
At a coagulant dose of 40 mg/L FeCl3 and a pH below 6.5, the
USEPA criteria was satisfied by removing more than 25% of DOC.
Under these enhanced coagulation conditions, a maximum removal of
3.0 logs of CoxB6, 1.75 log of Echo12, 2.5 logs of Polio1, 1.8 logs of fr,
1.3 logs of phi-X174, 0.36 logs of MS2, 0.29 logs of PRD1, and 41%
DOC was observed. Viral isoelectric points appear to heavily influence
the efficacy of removal by coagulation processes. Overall, CoxB6 was
removed more efficiently than the bacteriophages, indicating that they
may be suitable surrogates, with fr and phi-X174 being more
representative and MS2 and PRD1 being more conservative.
Bacteriophages MS2 and PRD1 appear to be the most suitable
surrogates for Echo12. The relative removal profiles of the
enteroviruses (greatest removal of coxsackievirus followed by
poliovirus and then echovirus) suggest that studies of the physical
removal of poliovirus may be extended to the CCL enteroviruses,
which may contribute to evaluations of their CCL and regulatory
status.
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